Get the Stockscreener App
0.00
100.00%
-15.82
After Hours:
15.90
15.90
+
Eyenovia Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Eyenovia Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or new combinations.
See More
Previous Close:
$15.82
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$11.76M
Revenue:
$31,800
Net Income/Loss:
$-37.83M
P/E Ratio:
0.00
EPS:
-0.71
Net Cash Flow:
$-30.64M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$43.20
Eyenovia Inc Stock (EYEN) Company Profile
Name
Eyenovia Inc
Sector
Industry
Phone
813-766-9539
Address
295 MADISON AVENUE,, NEW YORK, NY
Compare EYEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EYEN
Eyenovia Inc
|
0.00 | 11.76M | 31,800 | -37.83M | -30.64M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Eyenovia Inc Stock (EYEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-01-21 | Initiated | Northland Capital | Outperform |
| Feb-03-20 | Downgrade | Oppenheimer | Outperform → Perform |
Eyenovia Inc Stock (EYEN) Latest News
What MACD and RSI say about Eyenovia Inc.2025 Market Sentiment & Free High Accuracy Swing Entry Alerts - newser.com
Is Eyenovia Inc. stock in correction or buying zoneJuly 2025 Market Mood & Safe Entry Momentum Tips - newser.com
Analyzing Eyenovia Inc. with risk reward ratio chartsEntry Point & High Return Stock Watch Alerts - newser.com
Is Eyenovia Inc. stock poised for growthEarnings Miss & Long-Term Growth Plans - newser.com
How to escape a deep drawdown in Eyenovia Inc.2025 Top Decliners & Proven Capital Preservation Methods - newser.com
Backtesting results for Eyenovia Inc. trading strategies2025 Pullback Review & Risk Managed Trade Strategies - newser.com
Eyenovia Inc Stock Analysis and ForecastInsider Buying Signals & Compound Your Gains With Quality Stocks - earlytimes.in
Can volume confirm reversal in Eyenovia Inc.Long Setup & Weekly Return Optimization Plans - newser.com
What makes Eyenovia Inc. stock attractive to growth fundsTrade Signal Summary & Growth Oriented Trading Recommendations - newser.com
What institutional flow reveals about Eyenovia Inc.Bull Run & Fast Exit/Entry Strategy Plans - newser.com
Will Eyenovia Inc. stock sustain high P E ratiosJuly 2025 Highlights & Real-Time Buy Signal Notifications - newser.com
Is Eyenovia Inc. stock vulnerable to regulatory risksTrade Ideas & Safe Capital Preservation Plans - newser.com
Chart based analysis of Eyenovia Inc. trendsMarket Sentiment Summary & Verified Technical Trade Signals - newser.com
How interest rate cuts could boost Eyenovia Inc. stockJuly 2025 Levels & Expert Verified Movement Alerts - newser.com
Is a relief rally coming for Eyenovia Inc. holdersTrade Exit Summary & Trade Opportunity Analysis - newser.com
Has Eyenovia Inc. found a price floor2025 Retail Activity & Real-Time Volume Triggers - newser.com
What margin trends mean for Eyenovia Inc. stockJuly 2025 PostEarnings & Technical Pattern Alert System - newser.com
Will Eyenovia Inc. stock pay special dividendsPortfolio Performance Report & Pattern Based Trade Signal System - newser.com
How to build a dashboard for Eyenovia Inc. stockTrade Risk Report & Fast Entry High Yield Stock Tips - newser.com
Earnings visualization tools for Eyenovia Inc.2025 Trading Volume Trends & Weekly Top Gainers Alerts - newser.com
Eyenovia announces pricing of $1.9M registered direct offering - MSN
Mydriasis Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Viatris/Ocuphire Pharma, Eyenovia, Rayner Surgical/Omeros, Eyenovia, Taejoon Pharma - Barchart.com
What technical signals suggest for Eyenovia Inc. stockDip Buying & Free Reliable Trade Execution Plans - newser.com
Eyenovia Inc Stock (EYEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):